BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19368962)

  • 1. Towards randomized trials of cytoreductive surgery using peritonectomy and hyperthermic intraperitoneal chemotherapy for ovarian cancer peritoneal carcinomatosis.
    Chua TC; Liauw W; Robertson G; Chia WK; Soo KC; Alobaid A; Al-Mohaimeed K; Morris DL
    Gynecol Oncol; 2009 Jul; 114(1):137-9; author reply 139. PubMed ID: 19368962
    [No Abstract]   [Full Text] [Related]  

  • 2. Peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian peritoneal carcinomatosis: an argued role.
    Di Giorgio A; Cardi M; Sammartino P
    Gynecol Oncol; 2010 Apr; 117(1):146-7. PubMed ID: 20096922
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytoreductive surgery (cs) and hyperthermic intraperitoneal chemotherapy (hipec) in treatment of peritoneal surface malignances: report of a phase II clinical study.
    Asero S; Caruso M; Vallone N; Luciani AG; Lombardo V; Terranova G; Ettore G; Giannone G
    In Vivo; 2009; 23(4):645-7. PubMed ID: 19567402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of laparoscopic peritonectomy followed by intra-peritoneal chemohyperthermia: an experimental study.
    Ferron G; Gesson-Paute A; Classe JM; Querleu D
    Gynecol Oncol; 2005 Nov; 99(2):358-61. PubMed ID: 16112182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of pegylated liposomal doxorubicin administered by intraoperative hyperthermic intraperitoneal chemotherapy to patients with advanced ovarian cancer and peritoneal carcinomatosis.
    Salvatorelli E; De Tursi M; Menna P; Carella C; Massari R; Colasante A; Iacobelli S; Minotti G
    Drug Metab Dispos; 2012 Dec; 40(12):2365-73. PubMed ID: 22972909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: rationale and clinical data.
    de Bree E; Helm CW
    Expert Rev Anticancer Ther; 2012 Jul; 12(7):895-911. PubMed ID: 22845405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing evidence for change in ovarian cancer surgery--proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis.
    Chua TC; Liauw W; Robertson G; Morris DL
    Gynecol Oncol; 2009 Oct; 115(1):166-168. PubMed ID: 19604568
    [No Abstract]   [Full Text] [Related]  

  • 8. [Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis].
    Königsrainer I; Aschoff P; Zieker D; Beckert S; Glatzle J; Pfannenberg C; Miller S; Hartmann JT; Schroeder TH; Brücher BL; Königsrainer A
    Zentralbl Chir; 2008 Sep; 133(5):468-72. PubMed ID: 18924046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermic intraperitoneal chemotherapy in the management of ovarian cancer: A critical need for an evidence-based evaluation.
    Markman M
    Gynecol Oncol; 2009 Apr; 113(1):4-5. PubMed ID: 19176238
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database.
    Yan TD; Zappa L; Edwards G; Alderman R; Marquardt CE; Sugarbaker PH
    J Surg Oncol; 2007 Aug; 96(2):102-12. PubMed ID: 17221852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intraperitoneal chemotherapy in the treatment of advanced ovarian cancer].
    Classe JM; Muller M; Frenel JS; Berton Rigaud D; Ferron G; Jaffré I; Gladieff L
    J Gynecol Obstet Biol Reprod (Paris); 2010 May; 39(3):183-90. PubMed ID: 20116179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer.
    Helm CW; Bristow RE; Kusamura S; Baratti D; Deraco M
    J Surg Oncol; 2008 Sep; 98(4):283-90. PubMed ID: 18726895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer.
    Sugarbaker PH
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):15-24. PubMed ID: 19124999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The techniques of peritonectomy and hyperthermic intraperitoneal chemotherapy].
    Lang SA; Glockzin G; Dahlke MH; Popp FC; Agha A; Schlitt HJ; Piso P
    Zentralbl Chir; 2009 Sep; 134(5):443-9. PubMed ID: 19492282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.
    Glockzin G; Ghali N; Lang SA; Schlitt HJ; Piso P
    J Surg Oncol; 2009 Sep; 100(4):306-10. PubMed ID: 19697436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis arising from gastric cancer].
    Cotte E; Gilly FN; Beaujard AC; Glehen O
    Cancer Radiother; 2008 Nov; 12(6-7):653-8. PubMed ID: 18639480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is peritonectomy and hyperthermic intraperitoneal chemotherapy a new standard of treatment for advanced epithelial ovarian cancer?
    Farrell R
    Aust N Z J Obstet Gynaecol; 2019 Jun; 59(3):335-340. PubMed ID: 30706448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of quality of life of patients submitted to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis of gastrointestinal and ovarian origin and identification of factors influencing outcome.
    Macrì A; Maugeri I; Trimarchi G; Caminiti R; Saffioti MC; Incardona S; Sinardi A; Irato S; Altavilla G; Adamo V; Versaci A; Famulari C
    In Vivo; 2009; 23(1):147-50. PubMed ID: 19368140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach.
    Sugarbaker PH
    Expert Opin Pharmacother; 2009 Aug; 10(12):1965-77. PubMed ID: 19563273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.